Abstract
A 63-year-old woman developed consecutive visual loss in the presence of chronic renal failure on hemodyalisis, arterial hypertension, and pulmonary hypertension treated with sildenafil. Temporal artery biopsy was negative for giant cell arteritis. Bilateral, consecutive non-arteritic ischemic optic neuropathy was diagnosed. The implications and potential risk of sildenafil use in women are discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.
MeSH terms
-
Blindness / etiology
-
Fatal Outcome
-
Female
-
Humans
-
Hypertension / complications*
-
Hypertension, Pulmonary / complications*
-
Hypertension, Pulmonary / drug therapy
-
Kidney Failure, Chronic / complications*
-
Kidney Failure, Chronic / therapy
-
Middle Aged
-
Optic Neuropathy, Ischemic / diagnosis*
-
Optic Neuropathy, Ischemic / etiology
-
Phosphodiesterase 5 Inhibitors / adverse effects
-
Phosphodiesterase 5 Inhibitors / therapeutic use
-
Piperazines / adverse effects
-
Piperazines / therapeutic use
-
Purines / adverse effects
-
Purines / therapeutic use
-
Renal Dialysis
-
Risk Factors
-
Sildenafil Citrate
-
Sulfones / adverse effects
-
Sulfones / therapeutic use
-
Visual Acuity
Substances
-
Phosphodiesterase 5 Inhibitors
-
Piperazines
-
Purines
-
Sulfones
-
Sildenafil Citrate